Skip to main content


Fig. 5 | Respiratory Research

Fig. 5

From: ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways

Fig. 5

Effects of ZDHXB-101 on the expression of IL-13, IL-17 and MMP-9 in lung tissues. IL-13, IL-17 and MMP-9 mRNA and protein in the lung tissues were measured by q-PCR (a, c, e) and ELISA (b, d, f). The data represent means ± S.D. (n = 10), *p < 0.05 and ***p < 0.001 vs. the control group. #p < 0.05, ##p < 0.01, and ###p < 0.001 vs. the model group

Back to article page